Motley Fool Asset Management LLC Adma Biologics, Inc. Transaction History

Motley Fool Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.8 - $2.56 $1.29 Million - $1.84 Million	-718,797 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$2.04 - $3.74 $97,032 - $177,893	47,565 Added 7.09%	718,797 $1.6 Million
Q2 2020 Aug 12, 2020	BUY	$2.42 - $3.29 $140,686 - $191,264	58,135 Added 9.48%	671,232 $1.97 Million
Q1 2020 May 13, 2020	BUY	$1.5 - $4.59 $119,572 - $365,891	79,715 Added 14.95%	613,097 $1.77 Million
Q4 2019 Feb 11, 2020	BUY	$3.89 - $5.15 $334,843 - $443,301	86,078 Added 19.24%	533,382 $2.13 Million
Q3 2019 Nov 12, 2019	BUY	$3.19 - $5.39 $249,789 - $422,058	78,304 Added 21.22%	447,304 $1.99 Million
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $1.3 Million - $1.93 Million	369,000 New	369,000 $1.43 Million

339

182M

1.72M

846K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.05B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Motley Fool Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Motley Fool Asset Management LLC with notifications on news.